ImClone Investigational Site

Lexington, Kentucky 40604

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Colorectal Neoplasms, Metastases, Neoplasm

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed